FridayJul 30, 2021 11:11 am

Brain Biomarkers May Help to Accurately Predict ADHD Diagnosis

Research that was published in Frontiers in Physiology has found that communication among different regions in the brain, which is referred to as brain connectivity, could possibly serve as a biomarker for attention-deficit hyperactivity disorder (“ADHD”). For the study, researchers from the University of Buffalo in collaboration with the University of Cincinnati used machine-learning classifiers to identify grown-ups who had been diagnosed with ADHD during their childhood with 99% accuracy. The researchers note that these findings may be useful in helping clinicians find proper treatments that address the specific needs for each patient and may also increase the ease with…

Continue Reading

FridayJul 30, 2021 10:34 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Launches Second Stage of Manufacturing of Ibogaine for Clinical Research

The company has filed patent applications for two routes of chemical synthesis of ibogaine – offering potential advantages of improved isomeric purity, chiral purity, and easily isolated intermediate compounds Preliminary data indicates that the drug shows promise as a treatment for neuropathic pain and migraines, as well as the treatment of addiction The company is positioned to engage several markets, including digital therapeutics and research Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (“MINDCURE”), a diversified life sciences company at the forefront of the mental health industry, recently announced the launch of its second manufacturing stage of pharmaceutical-grade ibogaine to be…

Continue Reading

FridayJul 30, 2021 10:04 am

Brain Scientific Inc. (BRSF) Poised to Benefit as Rapidly Growing Brain-Computer Interface Field Drives EEG Growth

Brain-Computer Interface (“BCI”) market is expanding rapidly, expected to double to USD 406 billion by 2026 BCI technology, designed to acquire brain signals, analyze and translate them into commands, is one of key driving forces behind EEG technology growth Brain Scientific appears poised to capitalize on this novel technology as its applications expand from medical settings to training, consumer engagement, entertainment, and more The Brain-Computer Interface (“BCI”) field is growing rapidly, representing one of the main driving factors behind the expansion of EEG technology. As the provider of EEG technology, Brain Scientific (OTCQB: BRSF) appears well placed to leverage this…

Continue Reading

ThursdayJul 29, 2021 2:39 pm

Study Finds That Plant-Based Diets May Be Better for Heart Health

A recent study has discovered that diets rich in plant foods are better than low-fat diets when it comes to decreasing the risk of stroke and heart disease. The study monitored more than 5,000 Americans, with the scientists finding that individuals who ate diets low in saturated fat had lower LDL levels. Saturated fat is known to increase LDL cholesterol levels and is mostly found in animal products. LDL cholesterol, or low-density lipoprotein, is considered a bad cholesterol as it contributes to fatty buildup in the arteries. However, the researchers note that lower LDL levels didn’t translate to a lower risk…

Continue Reading

ThursdayJul 29, 2021 9:30 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Proprietary Imaging System Set to Advance Bladder Cancer Visualization

Approximatively 75-85% of patients with confirmed cases of bladder cancer are diagnosed with non-muscle invasive (“NMIBC”) Imagin Medical’s innovative technology is targeting this type of bladder cancer and set to be completed in 2022  Blue light cystoscopy helps surgeons visualize the cancerous cells that are not detected by white light, enabling an improved resection Non-muscle-invasive bladder cancer (“NMIBC”) is a type of bladder cancer that has not infiltrated the other muscle tissues inside the bladder or spread to the lymph nodes. Approximately 75-85% of patients presenting with bladder cancer are diagnosed with NMIBC. The most common symptoms of NMIBC which…

Continue Reading

ThursdayJul 29, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Globally Unlocking Data in the Complete Therapeutic Plant Lifecycle

Providing a holistic approach to therapeutic plant treatment by unlocking data from seed to consumption RYAH Group is providing needed dosing devices globally to drive innovation and deliver cutting edge plant-based medical solutions globally  With over 200k registered users, RYAH Group is one of the largest plant-based medicine databases in the world and regularly releases and shares valuable insights collected RYAH Group (CSE: RYAH), formerly RYAH Medtech, is leading the way forward by providing a holistic approach to therapeutic plant treatment by unlocking the data in the complete plant lifecycle (seed to consumption). Known for its high-quality information and digital…

Continue Reading

WednesdayJul 28, 2021 10:36 am

Researchers Discover New Phase in Stem Cell Cycle That May Help Develop Tumor Treatments

Researchers from Arizona State University are conducting a study on the life cycle of stem cells. The study may be useful in the development of new techniques for treating brain cancer. The research was reported in the “Molecular Systems Biology” journal. Assistant professor of biomedical engineering from the institution’s school of engineering Christopher Plaisier stated that the research team had discovered a new phase in the cycle during their study. This new information was discovered through an alliance with associate professor Patrick Paddison from the Fred Hutchinson Cancer Research Center and University of Washington’s assistant professor of neurological surgery Dr.…

Continue Reading

WednesdayJul 28, 2021 9:30 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Is ‘One to Watch’

MINDCURE’s proprietary digital therapeutics technology platform creates a high barrier to entry for any potential competitors The company maintains active partnerships with growing firms in AI, technology, and mental health MINDCURE’s world-class scientific discovery team has decades of combined experience in researching and commercializing pharmaceutical grade drugs The company has demonstrated a clear path to near-term revenues and boasts a strong financial position Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (“MINDCURE”) is a diversified life sciences company at the forefront of the mental health industry. The company is currently developing digital therapeutics and researching psychedelic compounds, while innovating and commercializing…

Continue Reading

WednesdayJul 28, 2021 9:00 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Files Patent, Adds New Dimension to Development Strategy

Digital therapeutics platform is proprietary to Cybin and the subject of the company’s 13th patent application Company focused on utilizing, leveraging cutting-edge technologies to support drug-development candidates Cybin is confident this added focus will better enable the evaluation of patient outcomes Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company, has taken another step forward in its strategic focus on progressing psychedelic therapeutics, with the filing of its 13th provisional patent application (https://ibn.fm/xTawm). In addition to the patent filing, the company has also advanced the build-out of its digital therapeutics strategy. “The digital therapeutics platform, which is proprietary to Cybin and the…

Continue Reading

TuesdayJul 27, 2021 1:30 pm

Danish Researchers Discover That Medical Marijuana May Combat Essential Tremor

There is huge debate on what medicinal properties, if any, marijuana possesses, and researchers are working to uncover the effects of this substance. For example, a team of researchers from the University of Copenhagen in Denmark has discovered that medical marijuana has the ability to reduce involuntary shaking or essential tremor. Their research used a mouse model. The team’s work focused on a synthetic cannabinoid WIN55.212-2. The scientists found that when the mice were injected with this cannabinoid, astrocytes or support cells found within the brain and spinal cord of the mice were activated. When those support cells are activated,…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050